Ronald Davis to Urinary Bladder Neoplasms
This is a "connection" page, showing publications Ronald Davis has written about Urinary Bladder Neoplasms.
Connection Strength
0.725
-
Davis RL, Le W, Cui Z. Granulocytes as an effector mechanism of BCG therapy for bladder cancer. Med Hypotheses. 2017 Jul; 104:166-169.
Score: 0.501
-
Packiam VT, Lamm DL, Barocas DA, Trainer A, Fand B, Davis RL, Clark W, Kroeger M, Dumbadze I, Chamie K, Kader AK, Curran D, Gutheil J, Kuan A, Yeung AW, Steinberg GD. An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. Urol Oncol. 2018 10; 36(10):440-447.
Score: 0.127
-
Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol. 2013 Aug; 27(8):1046-50.
Score: 0.096